{
    "organizations": [],
    "uuid": "ce943428a7afe66acd530a0ca6e9beb231473609",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sangamo-therapeutics-reports-q1-lo/brief-sangamo-therapeutics-reports-q1-loss-per-share-of-0-23-idUSASC0A0E6",
    "ord_in_thread": 0,
    "title": "BRIEF-Sangamo Therapeutics Reports Q1 Loss Per Share Of $0.23",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Sangamo Therapeutics Inc:\n* SANGAMO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.23 * Q1 EARNINGS PER SHARE VIEW $0.48 â€” THOMSON REUTERS I/B/E/S\n* SAYS EXPECTS THAT OPERATING EXPENSES WILL BE IN RANGE OF $140 MILLION TO $150 MILLION FOR YEAR-END 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T19:10:00.000+03:00",
    "crawled": "2018-05-09T12:37:16.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sangamo",
        "therapeutic",
        "inc",
        "sangamo",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "say",
        "expects",
        "operating",
        "expense",
        "range",
        "million",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}